These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12760891)

  • 1. Alpha interferon augments cidofovir's antiviral and antiproliferative activities.
    Johnson JA; Gangemi JD
    Antimicrob Agents Chemother; 2003 Jun; 47(6):2022-6. PubMed ID: 12760891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers.
    Abdulkarim B; Sabri S; Deutsch E; Chagraoui H; Maggiorella L; Thierry J; Eschwege F; Vainchenker W; Chouaïb S; Bourhis J
    Oncogene; 2002 Apr; 21(15):2334-46. PubMed ID: 11948417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of apoptosis by cidofovir in human papillomavirus (HPV)-positive cells.
    Andrei G; Snoeck R; Schols D; De Clercq E
    Oncol Res; 2000; 12(9-10):397-408. PubMed ID: 11697818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of Cidofovir on a naturally human papillomavirus-16 infected squamous cell carcinoma of the head and neck (SCCHN) cell line improves radiation sensitivity.
    Sirianni N; Wang J; Ferris RL
    Oral Oncol; 2005 Apr; 41(4):423-8. PubMed ID: 15792615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of human papillomavirus-induced cell proliferation by (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
    Johnson JA; Gangemi JD
    Antimicrob Agents Chemother; 1999 May; 43(5):1198-205. PubMed ID: 10223936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines.
    Andrei G; Snoeck R; Piette J; Delvenne P; De Clercq E
    Oncol Res; 1998; 10(10):523-31. PubMed ID: 10338155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
    Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human papillomavirus E7 protein is able to inhibit the antiviral and anti-growth functions of interferon-alpha.
    Barnard P; Payne E; McMillan NA
    Virology; 2000 Nov; 277(2):411-9. PubMed ID: 11080488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia.
    Andrei G; Topalis D; De Schutter T; Snoeck R
    Antiviral Res; 2015 Feb; 114():21-46. PubMed ID: 25446403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients.
    Orlando G; Fasolo MM; Beretta R; Signori R; Adriani B; Zanchetta N; Cargnel A
    AIDS; 1999 Oct; 13(14):1978-80. PubMed ID: 10513659
    [No Abstract]   [Full Text] [Related]  

  • 11. Cidofovir incorporation into human keratinocytes with episomal HPV 16 results in nonselective cytotoxicity.
    Spanos WC; El-Deiry M; Lee JH
    Ann Otol Rhinol Laryngol; 2005 Nov; 114(11):840-6. PubMed ID: 16363057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-tau exhibits potent suppression of human papillomavirus E6/E7 oncoprotein expression.
    Johnson JA; Hochkeppel HK; Gangemi JD
    J Interferon Cytokine Res; 1999 Oct; 19(10):1107-16. PubMed ID: 10547150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.
    Zabawski EJ; Cockerell CJ
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):741-5. PubMed ID: 9810890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
    Jiang M; Milner J
    Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity.
    Ruesch MN; Laimins LA
    J Virol; 1997 Jul; 71(7):5570-8. PubMed ID: 9188631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein.
    Jones DL; Münger K
    J Virol; 1997 Apr; 71(4):2905-12. PubMed ID: 9060648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large plantar wart caused by human papillomavirus-66 and resolution by topical cidofovir therapy.
    Davis MD; Gostout BS; McGovern RM; Persing DH; Schut RL; Pittelkow MR
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 2):340-3. PubMed ID: 10901717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of the antiviral agent cidofovir and anti-EGFR antibody cetuximab exerts an antiproliferative effect on HPV-positive cervical cancer cell lines' in-vitro and in-vivo xenografts.
    Deberne M; Levy A; Mondini M; Dessen P; Vivet S; Supiramaniam A; Vozenin MC; Deutsch E
    Anticancer Drugs; 2013 Jul; 24(6):599-608. PubMed ID: 23698251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of juvenile laryngeal papillomatosis-related multicystic lung disease with cidofovir: case report and review of the literature.
    Dancey DR; Chamberlain DW; Krajden M; Palefsky J; Alberti PW; Downey GP
    Chest; 2000 Oct; 118(4):1210-4. PubMed ID: 11035700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection.
    Snoeck R; Bossens M; Parent D; Delaere B; Degreef H; Van Ranst M; Noël JC; Wulfsohn MS; Rooney JF; Jaffe HS; De Clercq E
    Clin Infect Dis; 2001 Sep; 33(5):597-602. PubMed ID: 11477525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.